Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered question first ministerially corrected answering member label attachment file name title previous answer version answering member printed answering member label
tabling member	label

Search

1127283

registered interest
date	17/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to encourage fairer pricing by pharmaceutical companies for drugs supplied to the NHS.
tabling member constituency	Coventry South
tabling member printed	Mr Jim Cunningham
uin	255651
answer	answer is ministerial correction date of answer 22/05/2019 answer text <p>The 2019 Voluntary Scheme for Branded Medicines Pricing and Access, and the statutory scheme for branded medicines pricing, work together to control the cost of branded medicines to the National Health Service and ensure it stays within affordable limits.</p><p> </p><p>The 2019 Voluntary Scheme began on 1 January 2019 and will run for five years until the end of 2023. The Voluntary Scheme aims to provide stability and predictability for all parties in terms of the United Kingdom’s branded medicines expenditure and the medicines pricing and access environment for the period 2019 to 2023. It also aims to achieve a balance between patient access, affordability and supporting the development of innovative new medicines, including support for small companies.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 22/05/2019 14:30:06 answering member 4455 label Biography information for Seema Kennedy
tabling member	308 label Biography information for Mr Jim Cunningham

1127317

registered interest
date	17/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Bowel Cancer: Young People
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to reduce the number of young people developing bowel cancer.
tabling member constituency	Coventry South
tabling member printed	Mr Jim Cunningham
uin	255652
answer	answer is ministerial correction date of answer 22/05/2019 answer text <p>Obesity and poor diet are risk factors for bowel cancer in young people.</p><p>The second chapter of the world-leading childhood obesity plan was published in June 2018. This builds on the real progress made since the publication of chapter one in 2016, particularly in reformulation of the products our children eat and drink most. In chapter two we have set a bold ambition to halve childhood obesity by 2030 and significantly reduce the gap in obesity between children from the most and least deprived areas by 2030.</p><p>Many of the measures in both chapters of the plan will have an impact on tackling obesity across all age groups. These include the soft drinks industry levy, sugar reduction and wider calorie reformulation programme, restricting promotions and calorie labelling in restaurants which will improve our eating habits and reduce the amount of sugar we consume.</p><p>‘Childhood obesity: a plan for action, chapter 2’ is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/childhood-obesity-a-plan-for-action-chapter-2" target="_blank">www.gov.uk/government/publications/childhood-obesity-a-plan-for-action-chapter-2</a></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 22/05/2019 14:24:08 answering member 4455 label Biography information for Seema Kennedy
tabling member	308 label Biography information for Mr Jim Cunningham

1127327

registered interest
date	17/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diffuse Intrinsic Pontine Glioma
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of access to NHS support for sufferers of diffuse intrinsic pontine glioma.
tabling member constituency	Sheffield, Brightside and Hillsborough
tabling member printed	Gill Furniss
uin	255692
answer	answer is ministerial correction date of answer 22/05/2019 answer text <p>No specific assessment has been made by the Department at this time.</p><p>Care for children with Diffuse Intrinsic Pontine Glioma (DIPG) is co-ordinated and provided by Children’s Cancer Principal Treatment Centres (PTCs) working in conjunction with Paediatric Oncology Shared Care Units. Children’s Cancer PTCs are responsible for planning and delivering treatment for children with DIPG as well as ensuring these children can access wider support services such as psychology services, specialist play services and other therapies.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 22/05/2019 14:25:19 answering member 4455 label Biography information for Seema Kennedy
tabling member	4571 label Biography information for Gill Furniss

1127334

registered interest
date	17/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Isotretinoin: Side Effects
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential health risks and psychiatric side-effects of the drug Roaccutane.
tabling member constituency	Newcastle-under-Lyme
tabling member printed	Paul Farrelly
uin	255661
answer	answer is ministerial correction date of answer 22/05/2019 answer text <p>As with all medicines in the United Kingdom, the Medicines and Healthcare products Regulatory Agency continuously monitors the safety of isotretinoin-containing medicines. This includes reports of suspected adverse drug reactions submitted by healthcare professionals, patients and carers through the Yellow Card scheme, as well as published and unpublished data. As new evidence on safety emerges it is carefully evaluated and, where appropriate, product information is updated and advice for prescribers and patients is issued.</p><p>Specific assessments of possible psychiatric side effects associated with isotretinoin were considered by an Expert Working Group of the Commission on Human Medicines in 2005 and 2014. In addition, the risk of neuropsychiatric disorders was evaluated in a European review which was completed in 2018. This review concluded that the warnings in the product information for medicines containing isotretinoin regarding possible psychiatric adverse effects reflected what was known.</p><p>Since 1998, warnings regarding the possible risk of developing depression and other psychiatric side effects have been included in the product information for Roaccutane and the generic versions of isotretinoin (the Summary of Product Characteristics for healthcare professionals and the patient information leaflet). The product information for isotretinoin warns that treatment may be associated with possible psychiatric side effects, that particular care needs to be taken in patients with a history of depression; and that all patients on isotretinoin should be monitored for signs of depression and referred for appropriate treatment if necessary. It also states that stopping isotretinoin may not lead to improvement and therefore further psychiatric or psychological evaluation may be necessary.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 22/05/2019 16:42:43 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	1436 label Biography information for Paul Farrelly

1127168

registered interest
date	16/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Urinary Tract Infections
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to reduce unplanned hospital admissions resulting from urinary tract infections.
tabling member constituency	Hornsey and Wood Green
tabling member printed	Catherine West
uin	255355
answer	answer is ministerial correction date of answer 22/05/2019 answer text <p>In England, it is the responsibility of National Health Service commissioners to make decisions on individual treatments for urinary tract infections on the basis of the available evidence, taking into account guidance from the National Institute for Health and Care Excellence (NICE) where available. NICE guidance is always evidence based, adhering to the latest clinical thinking and research to determine the best treatment for patients.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 22/05/2019 14:26:35 answering member 4455 label Biography information for Seema Kennedy
tabling member	4523 label Biography information for Catherine West

1127170

registered interest
date	16/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Urinary Tract Infections
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans his Department has to improve the (a) reporting and (b) tracking of urinary tract infections in the NHS; and if he will make a statement.
tabling member constituency	Hornsey and Wood Green
tabling member printed	Catherine West
uin	255357
answer	answer is ministerial correction date of answer 22/05/2019 answer text <p>NHS Digital’s Hospital Episodes Statistics publishes data on finished consultant episodes with a primary or secondary diagnosis of urinary tract infection broken down by financial year, rather than by calendar year.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 22/05/2019 14:28:15 answering member 4455 label Biography information for Seema Kennedy
tabling member	4523 label Biography information for Catherine West

1127289

registered interest
date	16/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Drugs: Prices
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the affordability of medicines as a result of the redrafted WHO resolution entitled, Improving the transparency of markets for medicines, vaccines and other health-related technologies proposed by Italy on 29 April 2019.
tabling member constituency	Liverpool, Walton
tabling member printed	Dan Carden
uin	255695
answer	answer is ministerial correction date of answer 22/05/2019 answer text <p>The United Kingdom has a long-established and globally-recognised track record of assessing the price of new, innovative medicines by their clinical benefit and value, rather than by their development costs or international reference prices.</p><p>The UK will engage constructively with the talks at the World Health Assembly to achieve the best outcome for people here and globally, including in low and middle income countries. Pricing arrangements are the responsibility of Member States and are highly context specific, but the Department supports information sharing and mutual learning initiatives, where appropriate, in seeking to improve value for money for country procurement budgets.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 22/05/2019 14:32:11 answering member 4455 label Biography information for Seema Kennedy
tabling member	4651 label Biography information for Dan Carden

1126623

registered interest
date	14/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Baby Care Units: Mental Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of the adequacy of long-term mental health support given to parents of babies discharged from neonatal units.
tabling member constituency	Lewisham, Deptford
tabling member printed	Vicky Foxcroft
uin	254232
answer	answer is ministerial correction date of answer 22/05/2019 answer text <p>Perinatal mental health services are available to all parents, including parents of babies that have been discharged from neonatal units, when they need it.</p><p>In April 2019, NHS England confirmed that new and expectant mothers across the country are now able to access specialist mental health care in the area where they live. The rollout of specialist community services across the whole of England, means that those suffering from perinatal mental health problems are able to access high quality care much closer to home.</p><p> </p><p>The Five Year Forward View for Mental Health committed to invest £365 million from 2015/16 to 2020/21 in perinatal mental health services to ensure that, by 2020/21, at least 30,000 more women each year are able to access evidence-based specialist mental health care during the perinatal period.</p><p> </p><p>The NHS Long Term Plan includes a commitment for a further 24,000 women to be able to access specialist perinatal mental health care by 2023/24. Specialist care will also be available from preconception to 24 months after birth, which will provide an extra year of support. Support will also be extended to fathers and partners of women accessing specialist perinatal mental health services and maternity outreach clinics.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 22/05/2019 16:41:06 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4491 label Biography information for Vicky Foxcroft

1126321

registered interest
date	13/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Gender Dysphoria: Children
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government whether they intend to publish the results of the research project started in 2011 by the NHS Gender Identity Development Service Early pubertal suppression in a carefully selected group of adolescents with gender identity disorder; and if not, whether they will arrange for the data gathered by that study to be made available to other researchers.
tabling member printed	Lord Lucas
uin	HL15681
answer	answer is ministerial correction date of answer 22/05/2019 answer text <p>The research is an ethically approved study being carried out by the Tavistock and Portman NHS Foundation Trust since 2011, which is the largest provider of services for the alleviation of gender dysphoria in the United Kingdom.</p><p>The study will evaluate early pubertal suppression in a carefully selected group of adolescents with a clinical diagnosis of gender dysphoria. There are 44 young people taking part in the study.</p><p>The Tavistock and Portman NHS Foundation Trust has plans to publish the data <ins class="ministerial">on the blocker and cross-sex hormones, for those who were appropriate for this, as</ins><del class="ministerial">once</del> all of the young people in the study have reached <ins class="ministerial">this</ins><del class="ministerial">the</del> stage<ins class="ministerial">.</ins> <del class="ministerial">when a clinical decision is made about moving from pubertal suppressants to cross-sex hormones, which the Trust expects to occur in the next 12 months.</del></p> answering member printed Baroness Blackwood of North Oxford question first answered 22/05/2019 14:51:30 question first ministerially corrected 31/07/2019 15:30:59 answering member 4019 label Biography information for Baroness Blackwood of North Oxford previous answer version 119577 answering member printed Baroness Blackwood of North Oxford answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	1879 label Biography information for Lord Lucas

1125835

registered interest
date	09/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dental Health: Antibiotics
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government, further to the Written Answer by Lord O'Shaughnessy on 4 December 2018 (HL11750), how many antibiotic prescriptions were issued by general dental practitioners in England in 2018.
tabling member printed	Lord Colwyn
uin	HL15625
answer	answer is ministerial correction date of answer 22/05/2019 answer text <p>The Dental Prescribing Dashboard developed by the NHS Business Services Authority and Public Health England, includes data for National Health Service local area teams. Latest available data show general dental practitioners issued 2,912,579 prescriptions for all antimicrobials including antibiotics during April 2017 to March 2018. There were 715,545 prescriptions between January and March 2018. The Dental Prescribing Dashboard will be refreshed in summer 2019.</p><p>Analysis is based on items prescribed by NHS dentists, but some patients may attend a general medical practice with a dental infection and receive a prescription from their general practitioner (GP). These prescriptions are not included, as we cannot determine the reason why a GP prescribed antibiotics.</p><p>The <em>English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR) Report 2018</em> provides information on NHS dental prescribing in dental practices and consultations. The ESPAUR report for 2019 scheduled for publication later this year will publish data for the 2018 calendar year. The ESPAUR 2018 report is attached.</p> answering member printed Baroness Blackwood of North Oxford question first answered 22/05/2019 14:52:22 answering member 4019 label Biography information for Baroness Blackwood of North Oxford attachment 1 file name ESPAUR_2018_report.pdf title ESPAUR_2018_report
tabling member	3394 label Biography information for Lord Colwyn